Stereotactic body radiotherapy boost in patients with cervical cancer

References

• Albuquerque K, Tumati V, Lea J, Ahn C, Richardson D, Miller D, Timmerman R. 2020. A phase II trial of stereotactic ablative radiation therapy as a boost for locally advanced cervical cancer. International Journal of Radiation Oncology, Biology, Physics 106:464–471.
   PubMedGoogle Scholar
• Barraclough LH, Swindell R, Livsey JE, Hunter RD, Davidson SE. 2008. External beam boost for cancer of the cervix uteri when intracavitary therapy cannot be performed. International Journal of Radiation Oncology, Biology, Physics 71:772–778.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 68:394–424.
   PubMed Web of Science ®Google Scholar
• Cengiz M, Dogan A, Ozyigit G, Erturk E, Yildiz F, Selek U, et al. 2012. Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer. Brachytherapy 11:125–129.
   PubMed Web of Science ®Google Scholar
• Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, et al. 2020. Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline. Practical Radiation Oncology 10:220–234.
   PubMed Web of Science ®Google Scholar
• Corn BW, Hanlon AL, Pajak TF, Owen J, Hanks GE. 1994. Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix. Gynecologic Oncology 53:294–300.
   PubMed Web of Science ®Google Scholar
• Cox JD, Stetz J, Pajak TF. 1995. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). International Journal of Radiation Oncology, Biology, Physics 31:1341–1346.
   PubMed Web of Science ®Google Scholar
• Dalwadi S, Echeverria A, Jhaveri P, Bui T, Waheed N, Tran D, et al. 2020. Non-invasive stereotactic ablative boost in patients with locally advanced cervical cancer. International Journal of Gynecological Cancer 30:1684–1688.
   PubMed Web of Science ®Google Scholar
• Dimopoulos JC, Lang S, Kirisits C, Fidarova EF, Berger D, Georg P, et al. 2009. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. International Journal of Radiation Oncology, Biology, Physics 75:56–63.
   PubMed Web of Science ®Google Scholar
• Duru Birgi S, M, Gultekin, Yuce D., Yildiz F. 2018. Definitive treatment for locally advanced cervical cancer: a retrospective analysis from a singe institution. International Journal of Hematology and Oncology 28:19–29.
   Google Scholar
• Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. 2004. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. Journal of Clinical Oncology 22:872–880.
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. 2009. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). European Journal of Cancer 45:228–247.
   PubMed Web of Science ®Google Scholar
• Fokdal L, Sturdza A, Mazeron R, Haie-Meder C, Tan LT, Gillham C, et al. 2016. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: analysis from the retroEMBRACE study. Radiotherapy and Oncology 120:434–440.
   PubMed Web of Science ®Google Scholar
• Gill BS, Lin JF, Krivak TC, Sukumvanich P, Laskey RA, Ross MS, et al. 2014. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements. International Journal of Radiation Oncology Biology Physics 90:1083–1090.
   PubMed Web of Science ®Google Scholar
• Haas JA, Witten MR, Clancey O, Episcopia K, Accordino D, Chalas E. 2012. CyberKnife boost for patients with cervical cancer unable to undergo brachytherapy. Frontiers in Oncology 2:25.
   PubMedGoogle Scholar
• Haie-Meder C, Potter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. 2005. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiotherapy and Oncology 74:235–245.
   PubMed Web of Science ®Google Scholar
• Han K, Milosevic M, Fyles A, Pintilie M, Viswanathan AN. 2013. Trends in the utilization of brachytherapy in cervical cancer in the United States. International Journal of Radiation Oncology Biology Physics 87:111–119.
   PubMed Web of Science ®Google Scholar
• Holschneider CH, Petereit DG, Chu C, Hsu IC, Ioffe YJ, Klopp AH, et al. 2019. Brachytherapy: a critical component of primary radiation therapy for cervical cancer: from the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). Brachytherapy 18:123–132.
   PubMed Web of Science ®Google Scholar
• Hsieh CH, Tien HJ, Hsiao SM, Wei MC, Wu WY, Sun HD, et al. 2013. Stereotactic body radiation therapy via helical tomotherapy to replace brachytherapy for brachytherapy-unsuitable cervical cancer patients – a preliminary result. OncoTargets and Therapy 6:59–66.
   PubMed Web of Science ®Google Scholar
• Ito K, Kito S, Nakajima Y, Shimizuguchi T, Ogawa H, Nihei K, et al. 2019. Determining the recommended dose of stereotactic body radiotherapy boost in patients with cervical cancer who are unsuitable for intracavitary brachytherapy: a phase I dose-escalation study. Japanese Journal of Clinical Oncology 49:856–861.
   PubMed Web of Science ®Google Scholar
• Ito K, Shimizuguchi T, Karasawa K. 2019. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy. Japanese Journal of Clinical Oncology 49:270–275.
   PubMed Web of Science ®Google Scholar
• Kubicek GJ, Xue J, Xu Q, Asbell SO, Hughes L, Kramer N, et al. 2013. Stereotactic body radiotherapy as an alternative to brachytherapy in gynecologic cancer. BioMed Research International 2013:898953.
   PubMed Web of Science ®Google Scholar
• Lazzari R, Riva G, Augugliaro M, Vavassori A, Dicuonzo S, Cattani F, et al. 2020. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy. International Journal of Gynecological Cancer : official Journal of the International Gynecological Cancer Society 30:607–612.
   PubMed Web of Science ®Google Scholar
• Mantz CA. 2019. Definitive external beam radiation therapy with stereotactic body radiation therapy boost for FIGO stage IB - IIB cancer of the cervix: minimum 5-year disease control, toxicity, and quality of life outcomes from a phase 2 trial. International Journal of Radiation Oncology Biology Physics 105:S225.
   Google Scholar
• Marnitz S, Kohler C, Budach V, Neumann O, Kluge A, Wlodarczyk W, et al. 2013. Brachytherapy-emulating robotic radiosurgery in patients with cervical carcinoma. Radiation Oncology 8:109.
   PubMed Web of Science ®Google Scholar
• Neumann O, Kluge A, Lyubina O, Wlodarczyk W, Jahn U, Kohler C, et al. 2014. Robotic radiosurgery as an alternative to brachytherapy for cervical cancer patients. Strahlentherapie und Onkologie 190:538–545.
   PubMed Web of Science ®Google Scholar
• O'donnell B, Shiao JC, Pezzi TA, Waheed N, Sharma S, Bonnen MD, Ludwig MS. 2018. Stereotactic body radiation therapy, intensity-modulated radiation therapy, and brachytherapy boost modalities in invasive cervical cancer: a study of the National Cancer Data Base. International Journal of Gynecologic Cancer 28:563–574.
   PubMed Web of Science ®Google Scholar
• Palmgren J, Anttila M, Lahtinen T. 2014. Robotic stereotactic radiation therapy compared to 3D MR image guided HDR brachytherapy in the treatment of cervical cancer. International Journal of Radiation Oncology Biology Physics 90:S892.
   Google Scholar
• Pötter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. 2006. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiotherapy and Oncology 78:67–77.
   PubMed Web of Science ®Google Scholar
• Potter R, Tanderup K, Kirisits C, De Leeuw A, Kirchheiner K, Nout R, et al. 2018. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clinical and Translational Radiation Oncology 9:48–60.
   PubMed Web of Science ®Google Scholar
• Saibishkumar EP, Patel FD, Sharma SC, Karunanidhi G, Sankar AS, Mallick I. 2006. Results of external-beam radiotherapy alone in invasive cancer of the uterine cervix: a retrospective analysis. Clinical Oncology 18:46–51.
   Web of Science ®Google Scholar
• Sturdza A, Potter R, Fokdal LU, Haie-Meder C, Tan LT, Mazeron R, et al. 2016. Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiotherapy and Oncology 120:428–433.
   PubMed Web of Science ®Google Scholar
• Tanderup K, Fokdal LU, Sturdza A, Haie-Meder C, Mazeron R, Van Limbergen E, et al. 2016. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiotherapy and Oncology 120:441–446.
   PubMed Web of Science ®Google Scholar
• Viswanathan AN, Moughan J, Small W, Jr., Levenback C, Iyer R, Hymes S, et al. 2012. The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. International Journal of Gynecological Cancer 22:123–131.
   PubMed Web of Science ®Google Scholar
• Viswanathan AN, Thomadsen B, 2012. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy 11:33–46.
   PubMed Web of Science ®Google Scholar